UBS Group’s Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share OACB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,173
Closed -$7K 11468
2021
Q4
$7K Buy
6,173
+5,100
+475% +$5.59K ﹤0.01% 9227
2021
Q3
$1K Sell
1,073
-130
-11% -$139 ﹤0.01% 9421
2021
Q2
$1K Buy
+1,203
New +$1.41K ﹤0.01% 9300

Other funds holding OACB.WS

UBS Group's OACB.WS Position: Q1 2022 in Review

UBS Group sold out of Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share (OACB.WS) in Q1 2022, closing a stake of 6,173 shares — an estimated $7K sold.

UBS Group first reported a position in OACB.WS in Q2 2021 and held it in 3 quarters. The position peaked at $7K in Q4 2021. 31 funds tracked by Wall St. Rank hold OACB.WS as of Q1 2022.

  • UBS Group reported no remaining Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share position as of Q1 2022 after selling out during the quarter.
  • UBS Group sold 6,173 Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share shares in Q1 2022, an estimated $7K.
  • UBS Group first reported a position in Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share in Q2 2021 and held it in 3 quarters.
  • UBS Group's Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share position peaked at $7K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.